Drug Product
Company Overview
About
Haemopharm Healthcare is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Neurology
Quick Facts
HQ:Italy
Founded:2003
Employees:1,815
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Commercial Scale
Large Scale (Metric Ton+)
Markets Served
Asia-Pacific
Regulatory Approvals
Drug Approval WAWMA1
Health Canada · #APR-657FL3AB · 2020-10-01
Drug Approval N4ACQX
FDA · #APR-XBP8AZWZ · 2018-06-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-WME8S54X
Issued: 2020-07-20
Expires: 2025-11-14
WHO GMP
World Health Organization
Cert #: CERT-ZRU9E773
Issued: 2020-09-19
Expires: 2025-06-07
Loading CDMO intelligence...
Key facts about Haemopharm Healthcare
- Haemopharm Healthcare is headquartered in Italy.
- Haemopharm Healthcare was founded in 2003.
- Haemopharm Healthcare has 1,815 employees.
- Haemopharm Healthcare's capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like Haemopharm Healthcare
Directory pages this company appears in, each with the full list of matching manufacturers.